Precision Drilling
PDS
SilverCrest Metals
SILV
Dorian LPG
LPG
Halozyme Therapeutics
HALO
Lantheus
LNTH
US Stock MarketDetailed Quotes
EDAP EDAP TMS
- 2.530
- -0.007-0.28%
Trading Jan 7 09:52 ET
93.87MMarket Cap-4.13P/E (TTM)
2.590High2.530Low1.20KVolume2.590Open2.537Pre Close3.05KTurnover0.00%Turnover RatioLossP/E (Static)37.10MShares8.50052wk High2.12P/B75.38MFloat Cap2.12052wk Low--Dividend TTM29.79MShs Float21.640Historical High--Div YieldTTM2.37%Amplitude0.500Historical Low2.552Avg Price1Lot Size
EDAP TMS Stock Forum
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
EDAP TMS SA (Nasdaq: EDAP) announced the publication of the HIFI study results in European Urology, comparing Focal One® Robotic HIFU to radical prostatectomy (RP) for localized prostate cancer treatment. The landmark study, involving 3,328 patients across 46 centers, demonstrated that Focal One Robotic HIFU is non-inferior ...
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
EDAP TMS SA (Nasdaq: EDAP) and Avenda Health have launched the world's first AI-assisted Focal One® Robotic HIFU procedures for prostate cancer treatment. The collaboration integrates Avenda's FDA-cleared Unfold AI® technology with EDAP's Focal One robotic HIFU platform. Unfold AI creates 3D patient-specific cancer maps, enabling more precise tumor targeting and healthy tissue prese...
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
EDAP TMS SA (Nasdaq: EDAP) announced interim results from its Phase 3 study evaluating robotic High-Intensity Focused Ultrasound (HIFU) therapy for deep infiltrating endometriosis.
The study, involving 60 patients, aimed to assess acute pelvic pain levels. Key findings include:
1. Robotic HIFU therapy maintained an excellent safety profile, confi...
In reaction to earnings/guidance:
• $CalAmp (CAMP.US)$ +0.6%
Other news:
• $Cano Health (CANO.US)$ +6.1% ( $Humana (HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics (CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial (LPLA.US)$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona (XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX.US)$ +2.9% (tr...
$Alcoa (AA.US)$ $Avenue Therapeutics (ATXI.US)$ $Alibaba (BABA.US)$ $HeartBeam (BEAT.US)$ $Costco (COST.US)$ $EDAP TMS (EDAP.US)$ $FedEx (FDX.US)$ $Eli Lilly and Co (LLY.US)$ $Spero Therapeutics (SPRO.US)$ $Top Ships (TOPS.US)$ $T2 Biosystems (TTOO.US)$
No comment yet